Skip to content
OpenCapital
Get started

Stryker SYK Interest coverage

Interest coverage at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×
Medtronic logo
MedtronicMDT
9.1×+0.9×
STERIS logo
STERISSTE
18.1×+8.1×
Abbott logo
AbbottABT
14.4×+1.4×
Medline, Inc. logo
Medline, Inc. MDLN
2×+0.7×

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$115.45B-11.4%
Enterprise value$126.95B-12.4%
P/E34.6×-11.0×
P/S4.6×-1.0×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp

Returns & leverage

See full
Return on equity32.8%—
Debt / equity0.8×—
Current ratio2.1×+0.5×

Where this comes from

Calculated from Stryker’s reported figures.

ebit/interest expense=8×

Based on trailing twelve months.

The official record: Stryker’s 10-Q, filed May 2, 2025, on SEC EDGAR. View the filing →

Ask your AI about Stryker's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's interest coverage?
Stryker (SYK) reported interest coverage of 8× in Q1 2025.
How has Stryker's interest coverage changed year-over-year?
Stryker's interest coverage decreased by 27.3% year-over-year, from 11× to 8×.
What does interest coverage mean?
How many times the company's operating profit covers its interest bill.
How do you interpret interest coverage?
Higher is safer; below ~2× is a warning that earnings provide little cushion against the debt burden. Debt-free companies have no interest expense and the ratio is left blank.
How does interest coverage compare across companies?
Comparable across leveraged non-financials; less relevant for net-cash companies with negligible interest.